Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative ...
Stock futures pointed sharply higher Monday, led by chipmaker and tech shares, on optimism that the U.S. and China would strike a trade deal, with President Donald Trump and Chinese leader Xi Jinping ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する